secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001193125-25-275721
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio prices 15.1M share offering at $1.90, net proceeds ~$26.5M
-----------------------------------------------------------------

- Inovio sold 13.158M shares at $1.90; underwriters exercised option for 1.974M additional shares.
- Net proceeds expected ~$26.5M after discounts and expenses; closing November 12, 2025.
- Piper Sandler & Co. acted as sole book-running manager for the offering.
- Offering made under effective shelf registration statement; all shares sold by Inovio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312525275721/0001193125-25-275721-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312525275721/d80000d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-275721

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer